Clinical Trial Update: Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Heparin Early for Radial Access Percutaneous Coronary Intervention) [NA]

View source ↗

Summary

Clinical trial evaluating the timing of heparin administration during radial access PCI; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Heparin (unfractionated heparin)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Coronary Angiography, Percutaneous Coronary Intervention | NA | Status: RECRUITING